Company: BLCO
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0001860742-25-000004
Chunk: 420

Company: Bausch & Lomb Corp
Filing Date: 2025-02-19
Form: 10-K
Item: Item 1A
Chunk 420
---
240)(244)Other expense, net(44)(74)(13)Operating income162 130 207 Interest income15 15 6 Interest expense (Note 3)(399)(283)(146)Foreign exchange and other (12)(28)6 (Loss) income before provision for income taxes$(234)$(166)$73 Revenues by Segment and by Product CategoryRevenues by segment and product category were as follows:Vision CarePharmaceuticalsSurgicalTotal(in millions)202420232022202420232022202420232022202420232022Pharmaceuticals$4 $4 $4 $965 $614 $464 $— $— $— $969 $618 $468 Devices963 888 866 — — — 837 762 706 1,800 1,650 1,572 OTC1,724 1,611 1,461 — — — — — — 1,724 1,611 1,461 Branded and Other Generics40 32 31 241 220 214 — — — 281 252 245 Other revenues8 8 7 3 2 3 6 5 12 17 15 22 $2,739 $2,543 $2,369 $1,209 $836 $681 $843 $767 $718 $4,791 $4,146 $3,768 

F-60

The top ten products/franchises represented 55%, 54% and 53% of total revenues for the years 2024, 2023 and 2022, respectively.Geographic InformationRevenues are attributed to a geographic region based on the location of the customer for the years 2024, 2023 and 2022 and were as follows:(in millions)202420232022U.S. and Puerto Rico$2,413 $1,934 $1,695 China358 344 343 France227 210 195 Japan180 187 192 Germany152 147 138 United Kingdom132 121 108 Canada127 110 101 Russia120 106 132 Spain92 85 77 Italy91 82 72 Mexico75